Effector Therapeutics funding
Effector Therapeutics funding profile: $325M total raised. Latest round: Series A. Backed by GlaxoSmithKline's SR One, Novartis Venture Funds, Astellas Venture Management.
Headquarters: San Diego, California
Investors
- GlaxoSmithKline's SR One
- Novartis Venture Funds
- Astellas Venture Management
- Abingworth
- Osage University Partners
Fundraising guides
Browse the company funding database · Browse investors · Fundraising library
